With its higher surface expression, HLA‐E*01:03 inhibits NK cells via the NKG2A receptor more effectively than HLA‐E*01:01, in doing so reducing NK cell cytotoxicity against the tumour, resulting in increased relapse [99]. This evidence concerns the gene HLA-E and neoplasm.